Comparative in vitro activity of ceftolozane/tazobactam against clinical isolates of pseudomonas aeruginosa and enterobacterales from five latin american countries

HIGHLIGHTS

• who: Juan Carlos García-Betancur et al. from the Grupo Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, Colombia have published the article: Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries, in the Journal: Antibiotics 2022, 11, 1101. of /2022/
• what: The aim of this study was to evaluate the activity of C/T against clinical isolates of and collected from five American countries between 2016 and 2017 before its clinical use in and to compare it . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.